Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

General Practice YR3 > HTN, CKD and Hyperlipidaemia - prework > Flashcards

HTN, CKD and Hyperlipidaemia - prework Flashcards

1
Q

CKD - risk factors and aetiology

A
  • Diabetic nephropathy
  • Chronic glomerulonephritis
  • Chronic pyelonephritis
  • HTN
  • Adult PCKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Clinical features of CKD - early

A
  • Fatigue - build up of toxins and anaemia
  • Polyuria/nocturia
  • HTN - dysregulated fluid volume ratio and RAAS
  • Puffiness/swelling - eyes/ankles due to fluid retention
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical features CKD - later

A
  • Decreased urine output
  • Fluid overload symptoms - SOB, peripheral oedema, HTN
  • Uraemic symptoms - N+V, pruiritis, metallic taste in mouth
  • Neurological - difficult conc, coma/seizures
  • CV symptoms - chest pain/SOB
  • Anaemia
  • Bone mineral disease - bonepain and fractures
  • Metabolic acidosis - rapid breathing, confused
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical signs of CKD

A
  • Foamy/proteinuria
  • Pallor - anaemia
  • Peripheral oedema
  • HTN
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Investigations for CKD

A
  • UACR - first pass morning, 3mg/mmol or more = proteinuria
  • eGFR
  • Urine dip - haematuria?
  • Renal USS - obstruction?
  • BP, HbA1C and lipid profile - assess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Complications of CKD

A
  • CVD
  • Bone mineral disease
  • Anaemia
  • Peripheral neuropathy (toxic waste accumulation)
  • End stage kidney disease
  • Dialysis related complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Equation for CKD

A

Kidney failure risk equation - estimates likelihood of progression to ESRF with need of dialysis within 5 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When to refer to nephrologist?

A
  • eGFR less than 30ml/min/1.73m2
  • UACR more than 70mg/mmol
  • Accelerated reduction in eGFR (25% or 15ml within 12 months)
  • 5 year risk requiring dialysis of over 5%
  • Uncontrolled HTN despite 4 or more antihypertensives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BP targets CKD

A
  • Under 130/80 in patients under 80 with CKD and an ACR of more than 70mg/mmol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Management principles CKD

A
  • Control HTN
  • Optimise diabetic control
  • Avoid nephrotoxic drugs
  • Treat GN if cause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Medications for CKD that slow disease progression

A
  • ACEi or ARBs
  • SGLT2 inhibitors - specifically dapagliflozin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Reducing risk of CVD complications in CKD

A
  • Smoking cessation
  • Exercise
  • Healthy, balanced diet
  • Atorvastatin 20mg - in all patients with CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Managing complications of CKD

A
  • Oral sodium bicarbonate for metabolic acidosis
  • Iron and erythopoesis stimulating agents for anaemia (optimise iron levels first)
  • Vitamin D (eg alfacalcidol), low phosphate diet and phosphate binders for renal bone disease
  • Sometimes parathyroidectomy is needed
  • Osteoporosis can exist alongside and may be treated with bisphosphonates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of ESRD

A
  • Dialysis - many patients require IV iron when get to this stage
  • Special diet advice
  • Transplant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phosphate binders used in CKD

A
  • Calcium based binders - problem is can cause hypercalcaemia and vascular calcification
  • Sevelamer - non calcium based binder, binds to diet phosphate and prevents absorption, also seems to reduce uric acid levels and improve lipid profile in those with CKD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fluid overload in CKD

A
  • Sometimes furosemide is needed to control BP
  • Higher doses are sometimes needed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

When is dapagliflozin offered in CKD?

A
  • Diabetes plus urine ACR above 30mg/mmol
  • Also considered if diabetes + ACR 3-30mg/mmol and non diabetics with ACR 22.6mg/mmol or more
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What happens in renal bone disease?

A
  • Low calcium
  • High phosphate
  • Low vitamin D
  • Increased PTH
    Due to:
  • Reduced phosphate excretion
  • Lack of active vitamin D = less Ca2 absorbed from gut
  • Low Ca and high PO4 stimulate PTH to be released = increased bone turnover = osteomalacia
  • Osteosclerosis then occurs due to osteoblasts matching osteoclast activity but low Ca2+ means bone is not properly mineralised
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Spinal X-ray finding of renal mineral bone disease

A
  • Rugger jersey spine
  • Sclerosed both ends of each vertebral body (whiter) with osteomalacia in centre of body (less white)
  • Like stripes on rugby shirt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Follow up for CKD

A
  • Depends on clinical severity of CKD
  • At least annually
    *
21
Q

Risk factors HTN - primary

A
  • Age
  • Obesity
  • FH
  • High salt intake
  • Sedentery lifestyle
  • Alcohol consumption
22
Q

Causes of secondary HTN

A
  • Renal disease
  • Endocrine disease eg phaechromocytoma, primary hyperaldosteronism
  • Others: pregnancy, glucocorticoids, COCP, NSAIDs
23
Q

Symptoms HTN

A
  • Usually none unless BP is over 200/120
  • Can then get headaches, seizures or visual disturbances
24
Q

Investigations HTN

A
  • 24hr BP monitoring
  • Fundoscopy
  • Urine dip and UACR
  • ECG - LVH or ischaemic HD
  • Bloods - U&Es, Lipids, HbA1C
25
Q

Diagnosing and deciding whether to treat HTN

A
  • If BP between 140/90 and 180/120 - need to have 24 hr ambulatory or home readings submitted
  • Take readings from both arms - if higher than 140/90 rpt
  • Rpt if more than 20mmHg between each arm, consider causes for this
26
Q

When to consider immediate BP treatment?

A
  • When BP is 180/110 or more
  • If signs of papilloedema or retinal haemorrhages need same day specialist assessment
27
Q

Ambulatory vs home monitoring recommendation

A

Home:
* Take twice in morning and twice at night for 7 days (at least 4 days)
* Take at least 1 minute apart
* Discard first day and calculate average

Ambulatory:
* Use at least 14 readings to calculate average
* At least 2 measurements per hour during persons waking hours

28
Q

Lifestyle advice for HTN

A
  • Reduce salt intake - aiming for less than 6g/day but ideally less than 3g
  • Reduce caffeine intake
  • Stop smoking
  • Drink less alcohol
  • Balanced diet rich in fruit and veg
  • Exercise
  • Lose weight if overweight
29
Q

BP algorithm management

A
30
Q

BP targets dependent on age

A
  • If under 80 - below 140/90
  • 80 and over - below 150/90
    Ambulatory:
  • Under 80 - below 135/85
  • 80 and over - below 145/85
31
Q

Preventing AKI in CKD

A
  • Regular monitoring of Crt
  • Regular monitoring of renal function
  • Caution with nephrotoxic medications - esp if eGFR less than 60
  • Temporarily stop medications if at risk of AKI eg in acute illness with large fluid losses
  • Provide information leaflets to patinets eg Kidney Care UK
32
Q

Drugs which can cause AKI

A

Pre-renal:
* ACEi/ARBs
* NSAIDs
* Loop diuretics
* MRA eg spironolactone

Intrinsic/nephrotoxic:
* Abx
* NSAIDs
* PPIs
* Allopurinol
* Iodine based contrast
* Chemotherapy

33
Q

When should familial hypercholestrolaemia be suspected?

A
  • Total cholesterol greater than 7.5mmol/L and/or
  • Personal or FH of premature CHD (event before 60 in first degree relative eg parents, siblings, children)
34
Q

Signs of familial hypercholesterolaemia

A
  • Tendon xanthomas
  • Premature arcus senilis
35
Q

Familial hypercholestrolaemia treatment vs normal

A
  • High intensity lipid lowering treatment due to high risk of CVD
  • Genetic counselling
  • Specialist involvement needed
36
Q

Causes of secondary hyperlipidaemia

A
  • nephrotic syndrome
  • Hypothyroidism
  • Biliary obstruction
  • Pregnancy
  • Diabetes mellitus

Drugs:
* Steroids
* Beta blockers
* Excess alcohol intake
* Thiazide diuretics
* Oral contraceptives

37
Q

Special circumstances to consider statin regardless of QRISK

A

T1DM: Consider in all pts with condition, offer id:
* Over 40 or
* 10 or more years with diabetes or
* Established nephropathy or
* Other CVD RF

CKD:
* All patients
* Increase dose if greater than 40% reduction is achieved and eGFR is still more than 30, if lower consult nephrology

38
Q

How are statins grouped?

A
  • High medium and low intensity
  • How much effect they have on non-HDL cholesterol
39
Q

Follow up for people on statins

A
  • Lipid profile and LFTs at 3 months after commencing
  • If non-HDL cholesterol has not fallen by 40% discuss adherance and lifestyle
  • Consider increasing to 80mg atorvastatin
40
Q

What age is QRISK valid for? Who to not use it for?

A
  • Up to and including aged 84
  • Do not use in T1DM, eGFR less than 60 +/- albuminuria and familial hypercholsterolaemia family history
41
Q

When may QRISK underestimate CVD risk?

A
  • People treated for HIV
  • Serious mental health problems
  • Taking medicines that can cause dyslipidaemia eg antipsychotics, corticosteroids or immunosupressant drugs
  • People with autoimmune disorders/systemic inflammatory disorders eg SLE
42
Q

Lifestyle advice for hypercholestrolaemia - diet

A
  • Total fat should be 30% or less than total energy intake
  • Saturated fats 7% or less than total energy intake
  • Dietary cholesterol intake of less than 300mg/day
  • Replace saturated and monosaturated fats with olive oil, rapeseed oil or spreads with these in
  • Wholegrain varieties of starchy food
  • Reduce intake of sugar and refined sugars inc fructose
  • At least 5 portions of FRV /day
  • 2 portions of fish per week, one being oily fish
  • 4-5 portions of unsalted nuts, seeds or legumes per week
43
Q

Baseline bloods before commencing statin

A
  • Full lipid profile - non fasting
  • Creatine kinase
  • LFTs
  • Renal function inc eGFR
  • HbA1c
  • TSH - symptoms of under/over active thyroid `
44
Q

What else to ensure you record before commencing statin?

A
  • Alcohol consumption
  • BP
  • BMI
  • Smoking status
  • Diabetes status
45
Q

Aim of primary vs secondary prevention of statin use

A
  • Primary - greater than 40% reduction in non-HDL cholesterol levels
  • Secondary - achieve LDL-C of 2mmol/L or less, or non-HDL level of 2.6mmol/L or less
46
Q

Follow up after prescribing primary prevention statin

A
  • Measure total cholesterol, HDL and non-HDL cholesterol, LFTs in all people 2-3 months following change/initiation

If greater than 40% reduction in non-HDL is not acheived:
* Discuss adherance
* Lifestyle
* Consider increasing dose, if still not acheieved then consider ezetimibe

  • Then recheck LFTs again at 12 months
  • Provide annual medication review - consider annual full lipid profile
47
Q

Primary prevention of hypercholesterolaemia for those aged 85 and above

A
  • Consider offering without the need for QRISK assessment esp if smoke or have raised BP
  • Take into account benefits, preference, co-morbids, polypharmacy, frailty and life expectancy
48
Q

First line statin primary prevention vs secondary

A
  • Atorvastatin 20mg
  • Atorvastatin 80mg
49
Q
A

General Practice YR3 (31 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions